Cytovance Appoints Chief Technology Officer

Dr. Jesse McCool, former VP of Microbial Services, will serve the company as CTO

Cytovance Biologics announced today the appointment of Jesse McCool, Ph.D. as Chief Technology Officer.  Dr. McCool will continue to provide scientific and operational oversight as the SVP of R&D Services and will be responsible for leading Cytovance’s overall technology transformation.  “Jesse has been a driving force as part of the corporate leadership and has made significant contributions to the overall growth and success of Cytovance,” said Dr. Yan Wang, CEO. “His knowledge of our indu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters